Refine
Has Fulltext
- yes (31)
Is part of the Bibliography
- yes (31)
Year of publication
- 2016 (31) (remove)
Document Type
- Journal article (31) (remove)
Language
- English (31)
Keywords
- Fabry disease (4)
- Neuromyelitis optica spectrum disorders (NMOSD) (3)
- Optic neuritis (3)
- deep brain stimulation (3)
- ischemic stroke (3)
- Autoantibodies (2)
- Cerebrospinal fluid (2)
- Longitudinally extensive transverse myelitis (LETM) (2)
- Multiple sclerosis (2)
- Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) (2)
- Pain (2)
- Parkinson's disease (2)
- Parkinson’s disease (2)
- c-Fos (2)
- dopamine (2)
- enzyme replacement therapy (2)
- genetics (2)
- lymphocytes (2)
- macrophage (2)
- movement disorders (2)
- neuroinflammation (2)
- pain (2)
- 3D fluoroscopy (1)
- Adult patients (1)
- Agalsidase beta (1)
- Alzheimer’s disease (1)
- Anderson-Fabry Disease (1)
- Antibody index (1)
- Aquaporin-4 antibodies (AQP4-Ig, NMO-IgG)G (1)
- Aquaporin-4 antibodies (AQP4-IgG) (1)
- Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) (1)
- Ataxia (1)
- Azathioprine (1)
- Barkhof criteria (1)
- Brainstem encephalitis (1)
- CSF (1)
- Cell therapy (1)
- Cell-based assays (1)
- Cerebellitis (1)
- Cerebral-ischemia (1)
- Charcot-Marie-Tooth (1)
- Chronic neuropathic pain (1)
- D313Y genotype (1)
- DARPA (1)
- DYT1 (1)
- Devic’s syndrome (1)
- Diagnosis (1)
- Diplopia Internuclear ophthalmoplegia (INO) (1)
- Dose reduction (1)
- Dystonia (1)
- Edema (1)
- Electrophysiology (1)
- Enzyme replacement therapy (1)
- Evoked potentials (1)
- FP-CIT SPECT (1)
- FXIIa inhibitor rHA-Infestin (1)
- Fabry cardiomyopathy (1)
- Fabry nephropathy (1)
- Fabry-associated pain (1)
- Facial nerve palsy (1)
- Glatiramer acetate (1)
- Guillain-Barré-Syndrom (1)
- Head-injury (1)
- Hearing loss (1)
- Hemodynamic depression (1)
- IBA-1 (1)
- IPND criteria (1)
- IVIg (1)
- Infections (1)
- Interferon beta (1)
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (1)
- Intractable nausea and vomiting (1)
- Intravascular coagulation (1)
- Longitudinally extensive transverse myelitis (1)
- MOG-IgG (1)
- MRI (1)
- MRI criteria (1)
- MS (1)
- Macrophage (1)
- Magnetic resonance imaging (1)
- McDonald criteria (1)
- Mesenchymal stem/stromal cells (1)
- Methotrexate (1)
- Mice (1)
- Model (1)
- Molecular-weight heparin (1)
- Myelin oligodendrocyte glycoprotein (MOG) antibodies (1)
- Myelitis (1)
- NEUROWIND (1)
- NMOSD (1)
- Natalizumab (1)
- Neuromyelitis optica (NMO) (1)
- Neuromyelitis optica antibodies (NMO-IgG) (1)
- Neutrophil (1)
- OCB (1)
- Ofatumumab (1)
- Oligoclonal bands (1)
- Outcome (1)
- Outcome survey (1)
- PET (1)
- PI3K isoforms (1)
- Parkinson disease (1)
- Peripheral nervous system (1)
- Plasma extravasation (1)
- Pregnancy (1)
- Progressive supranuclear palsy (1)
- Randomized controlled-trial (1)
- Rats (1)
- Regenerative medicine (1)
- Respiratory insufficiency (1)
- Rhombencephalitis (1)
- Rituximab (1)
- Schwann cell dedifferentiation (1)
- Screening questionnaire (1)
- Small fiber dysfunction (1)
- System involvement (1)
- TBI (1)
- TSPO (1)
- Therapy (1)
- Thrombus formation (1)
- Tourette syndrome (1)
- Transverse Myelitis (1)
- Transverse myelitis (1)
- Treatment (1)
- Vaccination (1)
- Wingerchuk criteria 2006 and 2015 (1)
- adaptive immune system (1)
- alpha-galactosidase A (1)
- aneurysm surgery (1)
- angiography (1)
- aquaporin 4 (1)
- association (1)
- autoantibody (1)
- autoradiography (1)
- beta oscillations (1)
- biomarker (1)
- biopsy (1)
- blood coagulation (1)
- blood flow (1)
- botulinum toxin (1)
- cervical dystonia (1)
- clip control (1)
- closed-loop (1)
- coagulation factor XIIa (1)
- coherence analysis (1)
- collagens (1)
- contact activation system (1)
- contrast (1)
- conversion (1)
- dendric cells (1)
- depression (1)
- diffuse (1)
- disease (1)
- edema (1)
- essential tremor (1)
- factor XII (1)
- familial amyloidotic polyneuropathy (1)
- females (1)
- fibroblast (1)
- focal (1)
- gait analysis (1)
- genome-wide association study (1)
- glycation end products (1)
- guidelines (1)
- hip (1)
- image quality (1)
- imaging (1)
- immune cells (1)
- immunofluorescence (1)
- immunohistochemistry (1)
- in-vivo (1)
- inflammation (1)
- inherited metabolic disorders (1)
- innate immune system (1)
- integrins (1)
- intraoperative (1)
- intrathecal application (1)
- kinematics (1)
- knees (1)
- linkage (1)
- lyso-Gb3 (1)
- mechanical energy (1)
- mechanical thrombectomy (1)
- motor axonal neuropathy (1)
- motor control (1)
- mouse model (1)
- multiple sclerosis (1)
- multiple sklerosis (1)
- nerve fibers (1)
- neuromelanin (1)
- neuropathy (1)
- neutrophil (1)
- nodes of Ranvier (1)
- non-motor features (1)
- peripheral injury (1)
- physical therapy modalities (1)
- plasma extravasation (1)
- plasminogen (1)
- platelet activation (1)
- platelet aggregation (1)
- platelets (1)
- post-processing (1)
- post-traumatic stress disorder (1)
- quality-control (1)
- renal system (1)
- second hit (1)
- serotonin (1)
- skin diseases (1)
- subthalamic nucleus (1)
- thrombus formation (1)
- tool (1)
- tremor (1)
- velocity (1)
- vessel patency (1)
- walking (1)
- weight drop (1)
Institute
- Neurologische Klinik und Poliklinik (31) (remove)
Cervical dystonia (CD) is a movement disorder which affects daily living of many patients. In clinical practice, several unmet treatment needs remain open. This article focuses on the four main aspects of treatment. We describe existing and emerging treatment approaches for CD, including botulinum toxin injections, surgical therapy, management of non-motor symptoms, and rehabilitation strategies. The unsolved issues regarding each of these treatments are identified and discussed, and possible future approaches and research lines are proposed.